Fmoc-D-Dap(Dde)-OH

Fmoc-D-Dap(Dde)-OH is an Fmoc-protected, side-chain-modified amino acid derivative of D-2,3-diaminopropanoic acid (Dap), bearing a Dde-protected amino group on the side chain. The molecule contains an Fmoc carbamate on the α-amino functionality and a Dde (dehydroalanine-derived) protecting group on one of the side-chain amino groups, while the carboxylic acid remains unprotected as a free COOH for coupling chemistry. In peptide synthesis workflows, it functions as a protected building block that controls chemoselectivity by masking the α-amino and one side-chain amino during stepwise assembly, enabling orthogonal deprotection and subsequent functionalization of the remaining amino functionality for structure-activity studies or chemical biology conjugation strategies.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP25604

CAS No:210830-03-8

Synonyms/Alias:210830-03-8;(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-((1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl)amino)propanoicacid;AmbotzFAA1476;Fmoc-D-Dap(Dde)-OH;CTK8C0042;MolPort-006-705-614;0773AB;ANW-63928;AKOS015893077;ZINC100035904;VA50312;AJ-95461;AK-61241;KB-209609;RT-012936;A-8673;I04-1231;Na-Fmoc-Nss-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-D-2,3-diaminopropionicacid;(2R)-3-{[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]amino}-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}propanoicacid;D-Alanine,3-[[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]amino]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-;N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-beta-[(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl]-D-2,3-diaminopropionicacid;N-alpha-Fmoc-N-beta-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-D-2,3-diaminopropionicacid

Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-beta-[(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl]-D-2,3-diaminopropionic acid

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C28H30N2O6
M.W/Mr.
490,56 g/mole

Fmoc-D-Dap(Dde)-OH is an Fmoc-protected D-2,3-diaminopropanoic acid derivative bearing a Dde-protected side-chain amino group, providing orthogonal nitrogen protection for peptide chemistry. The molecule contains a stereogenic center at the alpha carbon in the D configuration, alongside two amino functionalities that are differentially masked to control chemoselective coupling and later deprotection. The Fmoc group on the alpha amine enables standard base-labile removal during solid-phase peptide synthesis, while the Dde (1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl) group is designed to be removed under hydrazine-based conditions without disturbing the Fmoc-protected backbone. The carboxylic acid and protected amine pattern makes the compound a chiral, peptide-compatible amino acid building block with a defined reactivity profile for sequential N-functionalization and downstream derivatization.

1. Peptide Synthesis

Fmoc-D-Dap(Dde)-OH supports peptide building block preparation for solid-phase peptide synthesis workflows where orthogonal amine protection is required. The Fmoc-protected alpha amine participates in routine peptide coupling after base-mediated Fmoc removal, while the Dde-protected side-chain amine remains masked to prevent side reactions during chain elongation. The D stereochemistry at the alpha carbon provides stereochemical control for incorporating D-amino acid residues into peptide sequences, including those used to tune proteolytic stability and conformational behavior. The resulting protected side-chain nitrogen can be selectively unmasked later to enable targeted branching, crosslinking, or attachment of functional moieties, aligning with peptide science and synthetic methodology development.

2. Side-Chain Functionalization

Fmoc-D-Dap(Dde)-OH enables side-chain functionalization strategies that rely on sequential deprotection of orthogonally protected amines. The Dde-protected side-chain nitrogen can be converted into reactive nucleophiles after selective removal, allowing formation of urea, amide, sulfonamide, or carbamate derivatives depending on the electrophile used in subsequent steps. The presence of a protected alpha carboxyl group in the amino acid form supports coupling-compatible elaboration into peptidomimetics and labeled analogs while maintaining the D-configuration integrity throughout synthesis. Downstream derivatization can generate libraries of Dap-bearing conjugates for structure-activity relationship studies, chemical biology probes, or scaffold diversification in fine chemical synthesis.

3. Bioconjugation Chemistry

Fmoc-D-Dap(Dde)-OH is suitable for bioconjugation workflows that require controlled presentation of an amine handle for linking biomolecules to probes or materials. The orthogonally protected side-chain amine provides a means to install a conjugation-ready nitrogen after selective Dde deprotection, minimizing undesired crosslinking during earlier synthetic stages. The Fmoc-protected backbone functionality supports incorporation into peptide carriers or peptide-based linkers, which can then be used to generate amide or amine-reactive conjugates for analytical research and biomolecule labeling. D-configuration incorporation can also be leveraged when designing conjugates intended for improved resistance to enzymatic degradation, supporting downstream formation of stable conjugate formats.

4. Chemical Biology Probes

Fmoc-D-Dap(Dde)-OH can be employed in chemical biology research to construct D-amino acid-containing peptide probes and receptor-binding mimetics with controlled nitrogen chemistry. The protected amines allow stepwise generation of defined interaction motifs, where the side-chain amino group can serve as a hydrogen-bonding or nucleophilic element after Dde removal. The Fmoc handle supports integration into peptide scaffolds for fragment-based molecular design and molecular recognition studies, while the D stereocenter provides stereochemical specificity that may influence binding conformations and protease susceptibility. The compound's peptide building block format facilitates systematic substitution and analog preparation for biochemical investigation and structure-activity relationship studies.

5. Pharmaceutical Intermediate Preparation

Fmoc-D-Dap(Dde)-OH serves as a chiral intermediate for manufacturing routes that require protected D-amino acid derivatives with orthogonal deprotection logic. The Fmoc group is compatible with base-mediated deprotection steps commonly used in peptide intermediate synthesis, while the Dde protecting group enables selective side-chain unmasking for downstream functional group installation. The defined stereochemistry and dual nitrogen protection pattern supports scalable synthesis of protected Dap-containing fragments used in drug discovery chemistry, peptidomimetic construction, and specialty chemical production. The resulting intermediates can be further transformed into amine-functionalized building blocks and conjugatable units used for process chemistry intermediate preparation and fine chemical synthesis programs.

Size
1 g;5 g;
InChI
1S/C28H30N2O6/c1-16(25-23(31)12-28(2,3)13-24(25)32)29-14-22(26(33)34)30-27(35)36-15-21-19-10-6-4-8-17(19)18-9-5-7-11-20(18)21/h4-11,21-22,29H,12-15H2,1-3H3,(H,30,35)(H,33,34)/t22-/m1/s1
InChI Key
IGNPBNCBFYUHTM-JOCHJYFZSA-N
Canonical SMILES
CC(=C1C(=O)CC(CC1=O)(C)C)NCC(C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Custom Conjugation ServicePeptide Modification ServicesPeptide Nucleic Acids SynthesisPeptide Synthesis ServicesPeptide CDMOEpitope Mapping ServicescGMP Peptide ServicePeptide Analysis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers